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The aim of the study was to investigate the biological effects 
in human lymphocytes irradiated with the 60 MeV proton 
beam in the Bronowice Cyclotron Center IFJ PAN. The 
relative biological effectiveness (RBE) of the proton beam in 
comparison to X-ray’s was estimated by the comet method. 
Whole blood samples were collected from 5 healthy donors. 
For dose-response studies lymphocytes were used submerged 
in agarose on microscopic slides, set in a specially designed 
PMMA phantom located at the isocenter. Cells were irradiated 
in Eppendorf vessels located in the mead of Spread-Out Bragg 
Peak (SOBP) in the fully modulated proton beam with range 
of 29 mm. 
For reference, the lymphocytes were exposed to the 250 kV 
X-rays. For both sources of radiations, dose-effect curves at a 
dose range (0-4Gy) were estimated. The level of DNA damage 
was assessed using the alkaline version of comet assay, also 
called the DNA single cell gel electrophoresis (SCGE). 
The obtained dose-response relationships for the level of DNA 
damage showed linear character for both sources of radiation 
(R2 = 0.994 for protons and R2 = 0.995 for X-rays). The 
efficiency of protons in inducing DNA strand breaks for the 
dose range from 0.3 to 4 Gy calculated as the ratio of the 
two α coefficients was 1.37. The average RBE calculated 
from the proton and X-ray dose required for the iso-effective 
TDNA comet assay parameter was 1.51 + / - 0.05 (range 1.45-
1.66).  
This observation suggests that the standard alkaline comet 
assay is reliable technique for estimation of DNA damage 
caused by proton and X-ray radiation in vitro. 
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Presently for production of medical radionuclides the 
cyclotrons are widely used which are very safe and reliable 
installations. At PNPI a high current cyclotron C-80 with the 
energy of extracted proton beam of 40-80 MeV and the 
current up to 200 μA has been constructed. One of the main 
goals of C-80 is production of a wide spectrum of medical 
radio-nuclides for diagnostics and therapy. At the beam of C-
80 the project of radioisotope complex RIC-80 (Radio Isotopes 
at the cyclotron C-80) has been worked out. In the presented 
submission the project of RIC-80 complex is discussed, which 
includes three target stations for production of radio-nuclides 
for medicine. The peculiarity of the proposed radio-isotope 
facility is the use of the mass-separator with the target-ion 
source device as one of the target stations for on-line, or 
semi on-line production of a high purity separated radio-
nuclides. The results on the target development for 
production of radio-isotope generator for PET diagnostics 82Sr 
are presented. 
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Purpose: Epithelial–mesenchymal transition (EMT) allows 
tumor cells to acquire the capacity to infiltrate surrounding 
tissue and to ultimately metastasize to distant sites. Limited 
information is available on the regulation of EMT in cervical 
cancer. Epidermal growth factor (EGF) has beenreported as a 
potent stimulator of cervical cancer invasiveness. 
Upregulation of epidermal growth factor receptor (EGFR) 
expression is reported in the recurrent cervical cancer. Fused 
Toes Homolog (FTS) has been reported as a general regulator 
of AKT activity in the control of differentiation, proliferation, 
and apoptosis in many cell types. Importantly, studies from 
our laboratory have shown overexpression of FTS in cervical 
cancer specimens and the expression of this protein increases 
with advancement of the disease. Hence, we studied the role 
of FTS in EGF-induced EMT in cervical cancer cells. 
Materials and Methods: A human cervical carcinoma cell line 
ME180 was used. Gene silencing was obtained using siRNA. 
Protein expression was studied by Western blot and 
immunofluorescence. Cell migration and invasion was 
assessed by wound healing and matrigel migration assay.  
Results: EGF treatment induced the change of EMT markers 
and increased cell migration. EGF treatment also increased 
phosphorylated EGFR and ERK and nuclear level of ATF-2. 
The binding of ATF-2 to the promoter region of FTS was 
evidenced after EGF treatment. Pretreatment with PD98059 
and gefitinib prevented EGF-induced FTS expression. FTS-
silencing reduced EMT and cell migration by EGF treatment. 
Conclusions: These results suggest that upregulation of FTS 
by EGF is mediated via EGF/EGFR/ERK/ATF-2 and this 
facilitates EGF-mediated EMT process in cervical cancer 
cells. FTS can be a potential target to circumvent cervical 
cancer progression driven by EGF. 
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Purpose: In PET-based treatment verification the low 
counting statistics PET data acquired during/after the 
treatment (Measured PET) must be compared to a Monte 
Carlo estimate of the β+ distribution induced by the 
treatment (Expected PET) based on the planning Computed 
Tomography (CT) images [1]. Given the extremely low quality 
of Measured PET images and the consequent difficulties in 
mismatch estimation, we proposed to use a 4D Maximum 
Likelihood (ML) reconstruction strategy considering Expected 
PET and Measured PET as two frames of a 4D dataset and 
providing an estimate of the motion field mapping one frame 
to the other [2]. 
The aim of this work is to optimize the strategy on a 
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simulated dataset mimicking real data characteristics, but 
provided with a ground truth for performance assessment. 
Materials/methods: Three possible implementations of the 4D 
ML reconstruction strategies are considered and 
schematically represented in Fig. 1. Briefly, Method 1 
(original version [2]) reconstructs the β+ distribution in a 
virtual reference frame and estimates the motion fields 
mapping it to the Expected and to the Measured PET frames. 
Method 2 reconstructs it in the Expected PET frame and 
estimates the motion field mapping Expected PET to 
Measured PET. Method 3, conversely, reconstructs in the 
Measured PET frame and estimates the motion field taking 
Measured PET to Expected PET. 
To initialize the reconstruction process a uniform activity 
distribution in the Filed Of View was considered. The three 
methods were validated on an analytical dataset simulating 
the β+ distribution induced by two orthogonal beams on an 
inhomogeneous tissue on a 200x200x50 voxel grid with voxel 
size 2mm. Poisson statistics, 66% washout and Gaussian 
mismatch between Expected and Measured PET were 
considered.  
Results were assessed after 30 iterations, by comparing: 1) 
the reconstructed Enhanced Measured PET with its ground 
truth, in terms of Normalized Mutual Information (NMI), Cross 
Correlation (CC) and Root Mean Square Error (RMSE); 2) the 
estimated motion field mapping Expected to Measured PET 
with its ground truth in terms of RMSE (RMSE_mot).  
Results: Results are presented in Table. 
 
 
 
 
 
 
Method 1 performs worst than the others since the number of 
motion unknown variables to be estimated is double. Method 
2 and method 3 perform similarly. Reconstructions were all 
initialized with a uniform activity distribution. The possible 
improvements of method 2 achievable with an initialization 
corresponding to Expected PET have still to be assessed.  
Conclusions: Three possible implementations of an innovative 
4D ML reconstruction strategy for PET-based treatment 
verification have been compared on a simulated phantom 
mimicking real data. The two methods halving the number of 
motion variables showed better performances. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1: The three compared methods are illustrated: a) 
Method 1, b) Method 2 c) Method 3. 
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Purpose: Particle therapy is an approach to tumor treatment 
which uses ion beams (in particular protons and carbon ions). 
The peculiar dose-depth relation of charged particles, that 
release most of their energy at the end of their range, 
enhances the dose conformity and the possibility to spare the 
healthy tissues. To exploit these features, the charged beam 
parameters needs to be carefully optimized by the Treatment 
Planning Systems (TPS). 
Commercial TPS are based on analytic representation in 
water (WEPL approach) of the patient and produce results in 
time of the order of hour(s). On the other hand Monte Carlo 
(MC) simulations can accurately take into account beam 
particle interactions, patient tissue morphology and 
elemental composition. Their application in the clinical 
routine is prevented by the huge amount of CPU needed to 
simulate the evolution of the beam in the patient.  
We developed a software (FRED) for MC dose calculation and 
Treatment Planning optimization for proton therapy that runs 
both on CPU and on GPU (Graphics Processing Units). FRED 
has been tailored on the CNAO delivery system in view of 
applications such as an independent dosimetric verification 
of TPS dose distributions and a fast recalculation of the TPS 
taking into account daily residual positioning uncertainties.  
Materials/Methods: FRED transports the protons in a 
voxelized geometry of the patient, retrieved from the DICOM 
information of the CT. The voxel HU of the CT is converted in 
elemental composition following the method by Schneider[1]. 
The stopping power is computed using conversion factors 
from the PSTAR tabulated values in water. Different models 
(single Gaussian, double Gaussian, Rutherford) can be used to 
reproduce Multiple Coulomb Scattering, while secondary 
protons and deuterons are produced in the beam nuclear 
interaction following the multiplicity, energy and angular 
distributions provided by ICRU63, and interpolated for other 
materials. Alpha and heavier fragments produced are treated 
as local dose deposition and (in this version) neutral particles 
are not produced. The RBE value of the proton is kept 
constant, but FRED could be easily interfaced with a library 
of RBE values. The FRED MC dose matrix can be processed by 
an optimizer based on a least-squares optimization algorithm 
as in [2]. All the output/input system has been adapted to 
the CNAO environment. 
Results: The agreement between the CNAO clinical depth-
dose database and the FRED results is within 1%. 
